Abstract:
Shares of Nanogen Inc. jumped more than 50 percent Wednesday after the company said it received a U.S. patent related to the fledgling field of nanotechnology and nanomanufacturing. San Diego-based Nanogen, which develops molecular diagnostic products for genetic testing, said the new patent could lead to nanoscale electronic and photonic devices for data storage or medical diagnostics. Nanogen Issued Key Nanotechnology Patent